首页> 外文期刊>Saudi journal of kidney diseases and transplantation : >Comparison of total direct cost of conventional single use and mechanical reuse of dialyzers in patients of end-stage renal disease on maintenance hemodialysis: A single center study
【24h】

Comparison of total direct cost of conventional single use and mechanical reuse of dialyzers in patients of end-stage renal disease on maintenance hemodialysis: A single center study

机译:终末期肾脏病患者在维持性血液透析中常规一次性使用和透析器的机械重复使用的总直接费用比较:一项单中心研究

获取原文
       

摘要

Reusing dialyzers is almost universal in developing countries to reduce the cost of hemodialysis (HD). Economic benefits of dialyzer reuse, when estimated only on the basis of the dialyzer and its consumables are very significant and attractive. In this study, we compared the cost of mechanical reuse of dialyzer considering all of the direct costs (medications, dialyzer, and its consumables, disinfection fluid, and hospitalization if any) in HD treatment, which if significantly different between single use and reuse, can nullify the obvious cost benefits. A total of 70 adult patients of any gender on maintenance HD at The Kidney Centre Post Graduate Training Institute for more than three months were included. Equal numbers of patients were on single use (Group A) and reuse of dialyzer (Group B). Both groups were compared for total direct costs of HD over a six months period. Average six monthly total direct cost per patient of Group A was significantly high as compared to Group B, the United States Dollar (USD) 1750.67 ± 135.31$ vs. USD 1488.50 ± 132.23$); difference USD 262.18$ (P <0.001). The total cost saving being 14.97% in Group B. Our study shows that dialyzer reuse provides a significant economic benefit and remains a means of reducing the cost of HD.
机译:为了降低血液透析(HD)的成本,在发展中国家几乎重复使用透析器。仅根据透析器及其消耗品来估计透析器再利用的经济利益是非常重要和有吸引力的。在这项研究中,我们比较了透析器的机械再利用成本,其中考虑了HD治疗中的所有直接成本(药物,透析器及其消耗品,消毒液和住院费用),如果一次性使用和再利用之间存在显着差异,可以消除明显的成本收益。总共包括70名在肾脏中心研究生训练所接受维持高清检查的成年患者,不论性别多于三个月。一次性使用(A组)和再次使用透析器(B组)的患者人数相同。两组都比较了六个月内高清的总直接成本。与B组相比,A组每位患者平均六个月的直接总费用要高得多,美元(USD)为1750.67±135.31 $,而美元为1488.50±132.23 $);差额262.18美元(P <0.001)。 B组的总成本节省为14.97%。我们的研究表明,透析器的重复使用可带来显着的经济效益,并且仍然是降低HD成本的一种手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号